ARCHIVES

Stone(y) Silence Didn’t Save His Job; Niamd’s Rall Rumored as Top Choice As New NIH Director

This article is from The Cancer Letter archive.

Vol. 01 No. 46 | December 20, 1974

Download PDF Visit The Full Archive

Related Articles

Oral Therapy Sorafenib Improves Survival Of Advanced Liver Cancer In Study

June 29, 2007

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

ACCC Annual Meeting To Study Organizing Community Care

January 26, 1979

FDA Committee Approves NDA for Mitxantrone

March 21, 1986

Clinton Budget Proposes Increase For AIDS, tuberculosis, In FY94

April 23, 1993

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998